Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01290627 · ClinicalTrials.gov registry record
In Vivo Determination of 3D Patellofemoral Mechanics
A clinical trial, sponsored by The University of Tennessee, Knoxville.
- Completed
- Registry status
- 30
- Enrollment target
NCT01290627: Completed study, sponsored by The University of Tennessee, Knoxville.
NCT01290627 is a clinical trial that has completed, run by The University of Tennessee, Knoxville. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01290627 has completed, sponsored by The University of Tennessee, Knoxville.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This study will analyze the tibio-femoral and patellofemoral (motion) and mechanics (forces) of participants having a normal knee or a total knee arthroplasty (TKA) using one or two different (TKA) devices Low Contract Stress (LCS) Posterior Stabilizing (PS) Rotating Platform (RP) Total Knee Arthroplasty (TKA). All knees will be analyzed using an image matching technique that will convert a two-dimensional (2D) fluoroscopic image into a three-dimensional (3D) image. In conjunction with the fluoroscopic analysis, electromyography (EMG) data, and ground reaction force (GRF) data will all be allow for a complete analysis of the knee joints. These results will help the orthopaedic community better understand knee motion so they can improve testing on existing implants and develop future implants that will further enhance patients' lives.
Primary Outcome
Full extension to maximum flexion. Degrees of flexion analyzed for participants with and without implants.
Interventions
- DEVICE Subjects implanted with DePuy LCS PS RP TKA
- DEVICE Subjects implanted with DePuy Sigma PS RP TKA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-02 |
| Est. Completion | 2011-09 |
What the finished NCT01290627 record still lists
NCT01290627 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Subjects implanted with DePuy LCS PS RP TKA is the first listed.
NCT01290627 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01290627 about?
NCT01290627 is a clinical study titled "In Vivo Determination of 3D Patellofemoral Mechanics". This study will analyze the tibio-femoral and patellofemoral (motion) and mechanics (forces) of participants having a normal knee or a total knee arthroplasty (TKA) using one or two different (TKA) devices Low Contract Stress (LCS) Posterior Stabilizing (PS) Rotating Platform (RP) Total Knee Arthrop...
What is the current status of trial NCT01290627?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2011-02. Estimated completion is 2011-09.
What interventions are being tested in trial NCT01290627?
The interventions under investigation include: Subjects implanted with DePuy LCS PS RP TKA (DEVICE), Subjects implanted with DePuy Sigma PS RP TKA (DEVICE).
Who is sponsoring clinical trial NCT01290627?
This trial is sponsored by The University of Tennessee, Knoxville, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia